Artesunate — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-28 in 3mo
ESTIMATED |
READOUT
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-a
Phase 2 · Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition |
Frantz Viral Therapeutics, LLC | Artesunate |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|